Gastric cancer (GC) is 4th in incidence and mortality rates globally. Several genetic and
epigenetic factors, including microRNAs (miRNAs), affect its initiation and progression …

Gastric cancers, with gastric adenocarcinoma (GAC) as the most common histological type,
impose a considerable global health burden. Although the screening strategies for early …

Bladder cancer (BC) is the 11th most popular cancer in females and 4th in males. A lot of
efforts have been exerted to improve BC patients' care. Besides, new approaches have …

Prolonged low-grade inflammation or smoldering inflammation is a hallmark of cancer. Mast
cells form a heterogeneous population of immune cells with differences in their ultra …

Prolonged low-grade inflammation or smoldering inflammation is a hallmark of a cancer.
Eosinophils are components of the immune microenvironment that modulates tumor …

Introduction. Gastric cancer is the fifth most common cancer and the third cause of cancer
death. The clinical outcomes of the patients are still not encouraging with a low rate of 5 …

Background Gastric cancer is an aggressive disease with a poor 5-year survival and large
global burden of disease. The disease is biologically and genetically heterogeneous with a …

Gastric cancer (GC) represents~ 10% of the global cancer-related deaths, increasingly
affecting the younger population in active stages of life. The high mortality of GC is due to …

Dysregulation of collagen type XII α1 chain (COL12A1) has been found in several cancer
types and could be involved in tumor progression. However, its clinical significance in …

During the last decade, novel immunotherapeutic strategies, in particular antibodies directed
against immune checkpoint inhibitors, have revolutionized the treatment of different …